0.31 CNY
253.90 M CNY
810.21 M CNY
820.97 M
About ZHEJIANG AUSUN PHARMACEUTICAL
Sector
CEO
Zhi Guo Zheng
Headquarters
Taizhou
Website
Founded
2010
ISIN
CNE100002XK2
FIGI
BBG00GBHXMB7
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical intermediates and raw materials. Its products include prostaglandin, active pharmaceutical ingredient (API), fluorine, and intermediates. The company was founded by Zheng Zhi Guo, Liu Bin and Mou Li Zhi on April 22, 2010 and is headquartered in Taizhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603229 is 9.94 CNY — it has increased by 9.96% in the past 24 hours. Watch ZHEJIANG AUSUN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHEJIANG AUSUN PHARMACEUTICAL stocks are traded under the ticker 603229.
603229 stock has risen by 4.63% compared to the previous week, the month change is a 19.90% rise, over the last year ZHEJIANG AUSUN PHARMACEUTICAL has showed a 6.23% increase.
We've gathered analysts' opinions on ZHEJIANG AUSUN PHARMACEUTICAL future price: according to them, 603229 price has a max estimate of 10.00 CNY and a min estimate of 10.00 CNY. Watch 603229 chart and read a more detailed ZHEJIANG AUSUN PHARMACEUTICAL stock forecast: see what analysts think of ZHEJIANG AUSUN PHARMACEUTICAL and suggest that you do with its stocks.
603229 reached its all-time high on May 11, 2022 with the price of 34.21 CNY, and its all-time low was 2.20 CNY and was reached on Oct 19, 2018. View more price dynamics on 603229 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603229 stock is 9.76% volatile and has beta coefficient of 1.36. Track ZHEJIANG AUSUN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is ZHEJIANG AUSUN PHARMACEUTICAL there?
Today ZHEJIANG AUSUN PHARMACEUTICAL has the market capitalization of 7.51 B, it has decreased by −1.21% over the last week.
Yes, you can track ZHEJIANG AUSUN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
603229 net income for the last quarter is 49.15 M CNY, while the quarter before that showed 67.35 M CNY of net income which accounts for −27.02% change. Track more ZHEJIANG AUSUN PHARMACEUTICAL financial stats to get the full picture.
Yes, 603229 dividends are paid annually. The last dividend per share was 0.13 CNY. As of today, Dividend Yield (TTM)% is 1.02%. Tracking ZHEJIANG AUSUN PHARMACEUTICAL dividends might help you take more informed decisions.
ZHEJIANG AUSUN PHARMACEUTICAL dividend yield was 0.98% in 2023, and payout ratio reached 30.13%. The year before the numbers were 0.34% and 13.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 1.17 K employees. See our rating of the largest employees — is ZHEJIANG AUSUN PHARMACEUTICAL on this list?
Like other stocks, 603229 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHEJIANG AUSUN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHEJIANG AUSUN PHARMACEUTICAL technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHEJIANG AUSUN PHARMACEUTICAL stock shows the buy signal. See more of ZHEJIANG AUSUN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.